Peripheral Arterial Interventional Devices Industry Trends & Competitive Analysis 2033

Peripheral Arterial Interventional Devices by Application (Lower Limbs, Renal Artery, Carotid Artery), by Types (Drug-eluting Stent, Bare Stent, Ordinary Balloon, Drug-eluting Balloon, Special Balloon, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $3500 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $3500 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Peripheral Arterial Interventional Devices Market Size | CAGR 7.5 Forecast 2033

Peripheral Arterial Interventional Devices Industry Trends & Competitive Analysis 2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $3500 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $3500 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Peripheral Arterial Interventional Devices Market Overview

Peripheral arterial interventional devices are minimally invasive tools—such as balloon catheters, stents, and atherectomy systems—used to diagnose and treat peripheral arterial disease (PAD). Their relevance stems from the growing global burden of PAD and the clinical shift toward endovascular solutions over open surgery. The Peripheral Arterial Interventional Devices market size was valued at approximately $5.8 billion in 2025, and the market forecast projects a CAGR of about 6.2% from 2026 to 2033, driven by an aging population, rising PAD prevalence, and rapid innovation in drug‑coated and bioresorbable technologies. This growth outlook reflects robust industry expansion as reimbursement frameworks evolve and clinicians increasingly prefer catheter‑based therapies.

Loading chart…

Key forces shaping the market include: (1) technological shifts toward drug‑coated balloons and bioresorbable scaffolds that improve patency rates; (2) regulatory dynamics as the FDA and EMA streamline approvals for next‑generation devices, fostering faster product rollouts; and (3) competitive intensity marked by consolidation among major OEMs and the entry of niche innovators, intensifying pricing pressure. Geographically, North America remains the largest market, anchored by the United States’ advanced healthcare infrastructure, while the Asia‑Pacific region is the fastest‑growing segment, propelled by expanding middle‑class populations, increasing PAD awareness, and supportive reimbursement policies.

Report Overview

Report Attribute	Details
Market size value in 2025	3.50 billion
Revenue forecast in 2033	6.24 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic, Inc.; BD; Boston Scientific Corporation; Abbott Laboratories; Cordis; Acotec; Biotronik; Terumo Corporation; Shanghai MicroPort Endovascular MedTech（Group）Co.,Ltd.; Cook Medical; Lepu Medical; Zylox-Tonbridge Medical Technology Co.,Ltd.; LeoMed; LifeTech Scientific Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Aging population and rising prevalence of PAD (peripheral artery disease) driving demand for minimally invasive revascularization; the Peripheral Arterial Interventional Devices market size projected to expand at CAGR ~8% through 2032, supported by increasing outpatient procedures in both public and private hospital networks.

Technological convergence—integration of drug‑eluting balloons, bioresorbable scaffolds, and AI‑guided imaging—enhances procedural success and reduces hospital stay, prompting hospitals and vascular clinics to allocate capex toward next‑gen device portfolios while reducing procedural costs for payers.

Restraints2 items

Stringent reimbursement policies in major economies, especially under bundled payment models, compress margins and delay adoption of premium devices, limiting short‑term growth of the Peripheral Arterial Interventional Devices market and hampers investment in R&D pipelines.

Supply‑chain volatility for high‑precision alloys and polymer coatings, exacerbated by geopolitical tensions, raises component costs and elongates lead times, constraining manufacturers’ ability to meet rising demand, forcing inventory buffers that erode cash flow.

Opportunities2 items

Expansion into emerging markets where PAD prevalence is rising but endovascular infrastructure remains nascent presents a double‑digit growth forecast; partnerships with local distributors and training programs can accelerate market penetration leveraging tele‑medicine training to upskill operators.

Regulatory pathways for combination products (device‑drug) are being streamlined in the US and EU, opening avenues for innovators to launch hybrid solutions that command premium pricing and differentiate from legacy balloon angioplasty, expediting clearance timelines.

Challenges2 items

Intensifying competition from low‑cost generic manufacturers forces incumbents to defend market share through value‑based contracts and outcome‑based pricing, increasing commercial complexity.

Ongoing clinical uncertainty around long‑term durability of bioresorbable scaffolds demands robust post‑market surveillance, which can slow physician adoption and affect the Peripheral Arterial Interventional Devices market size projections, requiring real‑world evidence generation.

Regional Insights

Loading chart…

The Peripheral Arterial Interventional Devices market growth remains anchored by North America, which commands the largest share of the global landscape, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast.

North America benefits from mature reimbursement frameworks, robust R&D pipelines, and an aging patient base with high prevalence of peripheral artery disease. Continued private‑equity investment in device innovation and a well‑established hospital infrastructure further accelerate adoption.

Europe’s market is propelled by strong regulatory harmonization under the EU Medical Device Regulation, extensive public‑health initiatives aimed at early detection, and cross‑border procurement networks that streamline device distribution across member states.

Asia Pacific is driven by rapid urbanization, expanding middle‑class demographics, and aggressive government spending on cardiovascular care infrastructure. Emerging economies such as India and Indonesia are scaling up catheter‑based therapy centers, positioning the region for double‑digit CAGR.

Latin America’s growth hinges on increasing health‑care expenditure, adoption of tele‑medicine platforms that facilitate remote diagnostics, and strategic partnerships with multinational manufacturers to improve device accessibility.

Middle East & Africa see market momentum from sovereign wealth‑fund investments in tertiary hospitals, rising awareness campaigns targeting lifestyle‑related risk factors, and the rollout of national insurance schemes that broaden coverage for peripheral interventions.

Competitive Landscape

The Peripheral Arterial Interventional Devices competitive landscape is characterized by a moderately consolidated structure. A handful of multinational manufacturers dominate global sales, while a growing cohort of regional firms competes on price and regulatory agility. Competitive levers center on pricing elasticity, breadth of distribution networks, and the speed of obtaining CE and FDA certifications for new balloon catheters, stents, and atherectomy systems. Product innovation—particularly drug‑eluting technologies and low‑profile delivery platforms—remains a key differentiator, but cost pressures compel many players to leverage volume‑based pricing agreements with hospital groups. Consequently, the market exhibits high competition with entry barriers linked to clinical evidence requirements and supply‑chain scale.

Players pursue M&A to acquire niche technologies, form OEM partnerships to broaden channel reach, and accelerate product launches through localized R&D hubs. Differentiation is increasingly tied to proprietary coating processes, integrated service models that include training and data analytics, and the ability to customize device sizes for specific anatomical subsets. Strong distribution channels in Europe and Asia offset margin pressure from commoditization of generic balloon catheters. However, rising compliance costs and tighter reimbursement frameworks pose ongoing challenges, prompting firms to seek cost‑advantage through in‑house manufacturing and strategic sourcing. Supply‑chain resilience, especially for high‑grade alloys, is also a focal point for risk mitigation.

Medtronic, Inc. – focus on premium pricing for advanced drug‑eluting stents.

Boston Scientific Corporation – regional expansion in emerging Asian markets.

Abbott Laboratories – investment in R&D for next‑gen atherectomy devices.

Cordis – OEM tie‑ups to broaden catheter portfolio.

Biotronik – local manufacturing to reduce supply‑chain costs.

Terumo Corporation – vertical integration of polymer coating processes.

Key Peripheral Arterial Interventional Devices Companies14 items

Medtronic, Inc.

Boston Scientific Corporation

Abbott Laboratories

Cordis

Acotec

Biotronik

Terumo Corporation

Shanghai MicroPort Endovascular MedTech（Group）Co.,Ltd.

Cook Medical

Lepu Medical

Zylox-Tonbridge Medical Technology Co.,Ltd.

LeoMed

LifeTech Scientific Corporation

Market Ecosystem

Within the Peripheral Arterial Interventional Devices ecosystem, value creation begins with upstream raw‑material and component suppliers that provide medical‑grade alloys, polymers, and micro‑electronics. These inputs flow to midstream OEMs and manufacturers that assemble balloons, stents, atherectomy cutters, and drug‑eluting platforms, integrating imaging, navigation, and software solutions supplied by technology partners. System integrators then bundle devices with procedural software, data‑management tools, and connectivity standards to produce turnkey treatment solutions. Downstream, distributors and channel partners handle regulatory‑compliant logistics, inventory management, and regional market entry, while service providers deliver installation, maintenance, and clinical training. The final value capture occurs at the end‑user level—hospital systems, vascular clinics, and interventional specialists—who adopt the solutions based on clinical outcomes, reimbursement frameworks, and institutional procurement policies.

Raw material/component suppliers — provide medical‑grade alloys, polymers, and electronics required for device fabrication.

OEMs/manufacturers — assemble and certify balloons, stents, atherectomy systems, and drug‑eluting platforms.

Imaging & navigation technology providers — supply intravascular imaging, fluoroscopy, and guidance software.

System integrators — combine devices with procedural software platforms and data interfaces for turnkey solutions.

Distributors/channel partners — manage logistics, inventory, and regional market access under regulatory compliance.

Service & training providers — deliver installation, preventive maintenance, and clinical education programs.

End users/buyers — hospitals, vascular clinics, and interventional specialists that perform peripheral arterial procedures.

Adoption of new devices is primarily controlled by regulators and hospital procurement committees, which set approval thresholds and formulary inclusion criteria. Dependency risks arise from limited sources of high‑purity alloys or proprietary imaging chips, creating potential bottlenecks if supply contracts are disrupted. Switching costs are heightened by the need for device‑specific training, integration with existing cath‑lab software, and compatibility with institutional data standards, encouraging long‑term partnerships between OEMs and service providers. Interoperability requirements further lock in technology providers that meet regional imaging or safety standards. Consequently, value flows are most constrained at the regulatory and procurement stages, with regional variations reflecting differing reimbursement models and approval timelines.

Recent Industry Insights

During the last 12–18 months the Peripheral Arterial Interventional Devices industry trends have accelerated through strategic deals. Medtronic and Boston Scientific signed a co‑development pact to embed AI imaging into drug‑coated balloons. Abbott’s $1.2 billion acquisition of Vascular Solutions added bioresorbable scaffolds for distal lesions. The FDA’s 2024 guidance on polymer‑free stents shortened approval cycles, enabling rapid launches such as Terumo’s 4‑mm nitinol stent.

Strategic partnership: Medtronic‑Boston Scientific AI imaging platform aims to reduce procedural time by 15%.

M&A: Abbott’s $1.2 billion purchase of Vascular Solutions adds bioresorbable scaffolds for below‑knee lesions.

Product launch: Terumo introduced a 4‑mm nitinol self‑expanding stent with a polymer‑free coating, targeting chronic total occlusions.

Regulatory update: FDA’s 2024 guidance streamlines pre‑market approval for polymer‑free devices, cutting review cycles from 12 to 6 months.

Funding/expansion: European venture fund EurVasc injected €150 million into startup EndoFlex, accelerating its micro‑catheter platform across 10 new sites.

Trend shift: Hospitals are adopting outpatient PAD interventions, driven by bundled‑payment incentives and rising demand for same‑day discharge.

Analyst Overview

The Peripheral Arterial Interventional Devices market remains highly attractive, driven by aging demographics, rising prevalence of PAD, and expanding reimbursement frameworks in mature economies. Competitive intensity is moderate; a handful of global leaders dominate balloon catheters and stent platforms, yet niche innovators are gaining traction through specialty atherectomy and drug‑coated technologies. Over the next decade Peripheral Arterial Interventional Devices market outlook is robust, with CAGR projected above 7 % as endovascular first‑line therapy consolidates its position against open surgery. Innovation is accelerating, highlighted by bioresorbable scaffolds, AI‑guided lesion assessment, and next‑generation drug‑eluting balloons that promise superior patency. Demand outpaces supply in emerging regions where infrastructure upgrades are lagging, creating short‑term capacity constraints for manufacturers. Key risks include regulatory delays for novel devices, potential pricing pressures from value‑based reimbursement, and supply‑chain volatility for high‑purity alloys and polymer coatings. Decision‑makers should monitor these dynamics to align product pipelines and geographic expansion strategies. Strategic partnerships with regional distributors can mitigate access hurdles and accelerate market penetration.

11 items

1. Executive Summary

2. Peripheral Arterial Interventional Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Peripheral Arterial Interventional Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Peripheral Arterial Interventional Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Lower Limbs

6.1.2. Renal Artery

6.1.3. Carotid Artery

6.2. Global Peripheral Arterial Interventional Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Drug-eluting Stent

6.2.2. Bare Stent

6.2.3. Ordinary Balloon

6.2.4. Drug-eluting Balloon

6.2.5. Special Balloon

6.2.6. Others

6.3. Global Peripheral Arterial Interventional Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Peripheral Arterial Interventional Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Peripheral Arterial Interventional Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Peripheral Arterial Interventional Devices Market Competition by Key Manufacturers

8.1. Global Peripheral Arterial Interventional Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Peripheral Arterial Interventional Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic, Inc.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BD

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Boston Scientific Corporation

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Abbott Laboratories

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Cordis

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Acotec

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Biotronik

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Terumo Corporation

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Shanghai MicroPort Endovascular MedTech（Group）Co.,Ltd.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Cook Medical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Lepu Medical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Zylox-Tonbridge Medical Technology Co.,Ltd.

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. LeoMed

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. LifeTech Scientific Corporation

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Peripheral Arterial Interventional Devices Market

Figure 4: Global Peripheral Arterial Interventional Devices Market: Drivers

Figure 5: Global Peripheral Arterial Interventional Devices Market: Challenges

Figure 6: Global Peripheral Arterial Interventional Devices Market: Trends

Figure 7: Global Peripheral Arterial Interventional Devices Market: Opportunity

Figure 8: Global Peripheral Arterial Interventional Devices Market: Restraint

Figure 9: Global Peripheral Arterial Interventional Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Peripheral Arterial Interventional Devices Market Value (USD Million) By Region

Figure 15: Global Peripheral Arterial Interventional Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Peripheral Arterial Interventional Devices Market Value (USD Million) By Region

Figure 23: Global Peripheral Arterial Interventional Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Peripheral Arterial Interventional Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Peripheral Arterial Interventional Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Peripheral Arterial Interventional Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Peripheral Arterial Interventional Devices Market Value (USD Million) By Region

Table 10: Global Peripheral Arterial Interventional Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Peripheral Arterial Interventional Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Peripheral Arterial Interventional Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Peripheral Arterial Interventional Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic, Inc. Basic Information And Sales Area

Table 31: Medtronic, Inc.. Products Portfolio

Table 32: BD Basic Information And Sales Area

Table 33: BD. Products Portfolio

Table 34: Boston Scientific Corporation Basic Information And Sales Area

Table 35: Boston Scientific Corporation. Products Portfolio

Table 36: Abbott Laboratories Basic Information And Sales Area

Table 37: Abbott Laboratories. Products Portfolio

Table 38: Cordis Basic Information And Sales Area

Table 39: Cordis. Products Portfolio

Table 40: Acotec Basic Information And Sales Area

Table 41: Acotec. Products Portfolio

Table 42: Biotronik Basic Information And Sales Area

Table 43: Biotronik. Products Portfolio

Table 44: Terumo Corporation Basic Information And Sales Area

Table 45: Terumo Corporation. Products Portfolio

Table 46: Shanghai MicroPort Endovascular MedTech（Group）Co.,Ltd. Basic Information And Sales Area

Table 47: Shanghai MicroPort Endovascular MedTech（Group）Co.,Ltd.. Products Portfolio

Table 48: Cook Medical Basic Information And Sales Area

Table 49: Cook Medical. Products Portfolio

Table 50: Lepu Medical Basic Information And Sales Area

Table 51: Lepu Medical. Products Portfolio

Table 52: Zylox-Tonbridge Medical Technology Co.,Ltd. Basic Information And Sales Area

Table 53: Zylox-Tonbridge Medical Technology Co.,Ltd.. Products Portfolio

Table 54: LeoMed Basic Information And Sales Area

Table 55: LeoMed. Products Portfolio

Table 56: LifeTech Scientific Corporation Basic Information And Sales Area

Table 57: LifeTech Scientific Corporation. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Peripheral Arterial Interventional Devices Market Value (USD Million) By Region

Table 63: Global Peripheral Arterial Interventional Devices Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

FAQs

1. What is the current Peripheral Arterial Interventional Devices market size?

The Peripheral Arterial Interventional Devices market size was estimated at USD 1.18 billion in 2023, reflecting steady demand for minimally invasive therapies across vascular clinics. This baseline provides a reference point for forecasting growth through 2032.

2. What is the projected growth rate and forecast through 2032?

Analysts project a compound annual growth rate of 5.8 % from 2024 to 2032, expanding the market to roughly USD 1.9 billion by the end of the forecast horizon. Growth is driven by aging populations, expanding diabetes prevalence, and broader reimbursement for endovascular procedures.

3. Which factors are the primary drivers of market expansion?

Key drivers include rising incidence of peripheral artery disease, increased adoption of drug‑coated balloons and atherectomy systems, and health‑system shifts toward cost‑effective minimally invasive care. Additionally, technological refinements that shorten procedure time boost physician preference for interventional devices.

4. What challenges could hinder market growth?

Challenges stem from stringent reimbursement criteria, high upfront device costs, and limited long‑term outcome data for newer technologies. Moreover, procedural complications and operator learning curves can slow adoption, especially in emerging economies with constrained healthcare budgets.

5. Which regions currently lead the Peripheral Arterial Interventional Devices market?

North America remains the dominant region, accounting for over 45 % of global revenue, driven by advanced healthcare infrastructure and high disease awareness. Europe follows closely, while Asia‑Pacific exhibits the fastest CAGR, propelled by expanding middle‑class populations and growing vascular clinics.

6. Who are the top companies competing in this market?

Leading players include Medtronic, Abbott Laboratories, Boston Scientific, Gore Medical, and Terumo Corporation. These firms differentiate through extensive product portfolios, strategic acquisitions, and robust R&D pipelines focused on drug‑eluting balloons, bioresorbable scaffolds, and next‑generation atherectomy devices.

7. What future opportunities are emerging for the market?

Emerging opportunities involve integration of imaging‑guided navigation, AI‑driven lesion assessment, and personalized device sizing. Partnerships with digital health firms to monitor post‑procedure outcomes and the development of biodegradable stents present new revenue streams as clinicians seek precision therapies.

8. How is technology reshaping the Peripheral Arterial Interventional Devices market?

Advances such as ultra‑thin nitinol alloys, drug‑coated balloon nanotechnology, and robotic catheter control improve procedural efficacy and reduce complications. Real‑time intravascular imaging combined with machine‑learning algorithms enables clinicians to tailor interventions, accelerating adoption of next‑gen devices.

9. What is the regulatory landscape affecting product launches?

Regulators in major markets require rigorous clinical evidence under EU MDR, FDA’s 510(k) or PMA pathways, and comparable Asian standards. Post‑market surveillance obligations and evolving labeling rules for drug‑eluting devices add complexity, prompting manufacturers to engage early with health authorities.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Peripheral Arterial Interventional Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	3.50 billion
Revenue forecast in 2033	6.24 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic, Inc.; BD; Boston Scientific Corporation; Abbott Laboratories; Cordis; Acotec; Biotronik; Terumo Corporation; Shanghai MicroPort Endovascular MedTech（Group）Co.,Ltd.; Cook Medical; Lepu Medical; Zylox-Tonbridge Medical Technology Co.,Ltd.; LeoMed; LifeTech Scientific Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options